Xuesi Wang
Overview
Explore the profile of Xuesi Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Liu X, Lin R, Peng X, Wang X, Meng F, et al.
Research (Wash D C)
. 2024 Oct;
7:0509.
PMID: 39469220
Ibrutinib, a potent Bruton's tyrosine kinase inhibitor with marked efficacy against hematological malignancies, is associated with the heightened risk of atrial fibrillation (AF). Although ibrutinib-induced AF is linked to enhanced...
2.
Wang X, Peng X, Li Y, Lin R, Liu X, Ruan Y, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(12):387.
PMID: 39076666
Background: Post-cardiac procedure atrial fibrillation (PCP-AF) is a significant medical problem. Inflammation is one of the key factors in the pathogenesis of PCP-AF. As a classical anti-inflammatory drug, colchicine may...
3.
Li Y, Liu X, Lv W, Wang X, Du Z, Liu X, et al.
BMC Med
. 2024 Jun;
22(1):269.
PMID: 38926749
Background: In the USA, the prolonged effective survival of cancer population has brought significant attention to the rising risk of cardiometabolic morbidity and mortality in this population. This heightened risk...
4.
Lin R, Peng X, Li Y, Wang X, Liu X, Jia X, et al.
Mol Cell Biochem
. 2023 Aug;
479(8):2105-2118.
PMID: 37648958
In animal studies, sodium-glucose co-transporter-2 inhibitors-such as empagliflozin-have been shown to improve heart failure and impaired cardiac contractility induced by anthracyclines-including doxorubicin-although the therapeutic mechanism remains unclear. Moreover, abnormalities in...
5.
Li Y, Peng X, Wang X, Lin R, Liu X, Meng F, et al.
BMC Public Health
. 2023 Jun;
23(1):1094.
PMID: 37280597
Background & Aims: The individual effect of working schedule on survival in the hypertensive population has not been adequately studied. Shiftworkers are also prone to unhealthy lifestyles like pro-inflammatory diet....
6.
Peng X, Wang J, Li J, Li Y, Wang X, Liu X, et al.
ESC Heart Fail
. 2023 Mar;
10(3):1883-1895.
PMID: 36967134
Aims: Heart failure (HF) is one of the leading causes of the global burden of disability and mortality. However, the comprehensive epidemic status of HF in China is unclear. Notably,...
7.
Liu X, Lin R, Peng X, Wang X, Li Y, Liu X, et al.
Europace
. 2023 Mar;
25(4):1352-1360.
PMID: 36857524
Objective: This study aimed to evaluate the feasibility of real-time visualization and mapping of the right phrenic nerve (RPN) by using intracardiac echocardiography (ICE) during atrial fibrillation (AF) ablation. Background:...
8.
Li Y, Lin R, Peng X, Wang X, Liu X, Li L, et al.
Oxid Med Cell Longev
. 2022 Oct;
2022:3659278.
PMID: 36187332
Cardiotoxicity is the major side effect of anthracyclines (doxorubicin, daunorubicin, epirubicin, and idarubicin), though being the most commonly used chemotherapy drugs and the mainstay of therapy in solid and hematological...
9.
Peng X, Li Y, Wang X, Ruan Y, Liu N
Front Cardiovasc Med
. 2022 May;
9:739113.
PMID: 35498047
Background: The impact of elevated resting heart rate on early-stage renal dysfunction, manifesting as microalbuminuria, in hypertension is unclear. This study aimed to analyze the association between resting heart rate...
10.
The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
Li Y, Peng X, Lin R, Wang X, Liu X, Bai R, et al.
Front Physiol
. 2022 Mar;
13:850117.
PMID: 35356081
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe yet rare inherited arrhythmia disorder. The cornerstone of CPVT medical therapy is the use of β-blockers; 30% of patients with CPVT do...